Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
International Journal of Cancer
|
January 24, 2023
Molnupiravir is effective in patients with haematological malignancies
Łukasz Bołkun, Bartosz Pula, Agnieszka Kołkowska-Leśniak, et al.
Annals of Hematology
|
July 1, 2023
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group
Anita Soboń, Joanna Drozd-Sokołowska, Ewa Paszkiewicz-Kozik, et al.
Scientific Reports
|
July 30, 2025
Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomes
Agnieszka Giza, Paulina Dumnicka, Elżbieta Kalicińska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
Michael Wang, David Salek, David Belada, et al.
British Journal of Haematology
|
February 18, 2026
Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma
Krzysztof Jamroziak, Dominik Dytfeld, Tadeusz Kubicki, et al.
Oncotarget
|
August 17, 2016
Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy
Dominik Dytfeld, Magdalena Luczak, Tomasz Wrobel, et al.
Contemporary Oncology (Poznan, Poland)
|
May 7, 2025
Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group
Oktawia Sośnia, Elżbieta Iskierka-Jażdżewska, Anna Puła, et al.
Contemporary Oncology (Poznan, Poland)
|
October 16, 2025
Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group
Oktawia Sośnia, Elżbieta Iskierka-Jażdżewska, Anna Puła, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|
January 5, 2023
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group
Ewa Paszkiewicz-Kozik, Iwona Hus, Monika Palka, et al.
Cancers
|
February 15, 2022
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
Bartosz Puła, Katarzyna Pruszczyk, Ewa Pietrusza, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
International Journal of Cancer
|
January 24, 2023
Molnupiravir is effective in patients with haematological malignancies
Łukasz Bołkun, Bartosz Pula, Agnieszka Kołkowska-Leśniak, et al.
Annals of Hematology
|
July 1, 2023
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group
Anita Soboń, Joanna Drozd-Sokołowska, Ewa Paszkiewicz-Kozik, et al.
Scientific Reports
|
July 30, 2025
Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomes
Agnieszka Giza, Paulina Dumnicka, Elżbieta Kalicińska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
Michael Wang, David Salek, David Belada, et al.
British Journal of Haematology
|
February 18, 2026
Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma
Krzysztof Jamroziak, Dominik Dytfeld, Tadeusz Kubicki, et al.
Oncotarget
|
August 17, 2016
Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy
Dominik Dytfeld, Magdalena Luczak, Tomasz Wrobel, et al.
Contemporary Oncology (Poznan, Poland)
|
May 7, 2025
Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group
Oktawia Sośnia, Elżbieta Iskierka-Jażdżewska, Anna Puła, et al.
Contemporary Oncology (Poznan, Poland)
|
October 16, 2025
Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group
Oktawia Sośnia, Elżbieta Iskierka-Jażdżewska, Anna Puła, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|
January 5, 2023
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group
Ewa Paszkiewicz-Kozik, Iwona Hus, Monika Palka, et al.
Cancers
|
February 15, 2022
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
Bartosz Puła, Katarzyna Pruszczyk, Ewa Pietrusza, et al.
Page
of 6